EurekAlert – With the help of the CRISPR/Cas9 gene scissors, researchers at Lund University Diabetes Centre in Sweden have managed to "turn off" an enzyme that proved to play a key role in the regulation of the diabetes-associated TXNIP gene.
Forbes – We need and can afford both to raise the bar so that everyone has access to modern healthcare, and to advance treatments through medical science. There’s no dichotomy between healthcare for all and research.
Recode – Trump wants to privatize air traffic management, according to Rep. Bill Shuster, R-Pa., who says the president-elect is in favor of replacing the current Federal Aviation Administration-run system with a private, nonprofit corporation.
Vocativ – On Wednesday, the House of Representatives overwhelmingly approved the 21st Century Cures Act. One of the most controversial measures would accelerate the regulatory review of stem cell therapies.
MIT Technology Review – The deaths last month of two patients in a clinical trial testing a promising new type of cancer treatment are raising questions about the fate of drugs that use a patient’s own immune cells to fight off the disease.
STAT – Two studies published Thursday found that a single dose of psilocybin, the psychoactive ingredient found in hallucinogenic mushrooms, can produce immediate, lasting, and positive effects for cancer patients with anxiety and depression.
The New England Journal of Medicine – The current excitement over the potential for stem-cell therapy is understandable. However, we must first understand its risks and benefits and develop therapeutic approaches based on sound science.